Skip to content

AdaptHealth AHCO Respiratory Health — Goodwill impairment (note 7)

Other segment segments

Diabetes Health
$128M
Sleep Health
$0
Wellness at Home
$0

Similar metrics at other companies

Fox Factory Holding Corp. logo
FOXFGoodwill impairment
$139.33M
Driven Brands Holdings Inc. logo
DRVNGoodwill impairment
$7.08M
Bausch Health Companies logo
BHCGoodwill impairments
$1.43B
Harmonic logo
HLITGoodwill Impairment
$14.38M
Bausch Health Companies logo
BHCGoodwill impairments
$1.43B
Horace Mann Educators logo
HMNSupplemental & Group Benefits — Goodwill, Impairment Loss
$0

Other financials

Income statement

See full
Revenue$819.8M+5.4%
Gross profit$111.5M-7.4%
Operating income$5.5M-76.3%
Net income-$16.0M-123%
EPS (diluted)-$0.12-140%

Balance sheet

See full
Cash & equivalents$48.0M-10.6%
Total debt$2.0B-4.9%
Total equity$1.5B-3.9%
Total assets$4.4B-0.3%

Cash flow

See full
Operating cash flow$93.7M-1.9%
CapEx$121.2M+26.8%
Free cash flow-$27.5M-47,297%

Valuation

See full
Market cap$1.36B+20.5%
Enterprise value$3.32B+4.3%
P/S0.4×+0.1×

Profitability

See full
Gross margin18.3%-1.6pp
Operating margin8%+6.9pp
Net margin-2.4%-5.1pp
FCF margin5.8%-2.6pp

Returns & leverage

See full
Return on equity-5.2%-10.8pp
Debt / equity1.3×0.0×
Current ratio0.9×-0.4×

Where this comes from

Reported directly by AdaptHealth in its filing.

Tagged under the XBRL concept us-gaap:GoodwillImpairmentLoss.

The official record: AdaptHealth’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about AdaptHealth's respiratory health — goodwill impairment (note 7).

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AdaptHealth's respiratory health — goodwill impairment (note 7)?
AdaptHealth (AHCO) reported respiratory health — goodwill impairment (note 7) of $0 in Q4 2025.
What does respiratory health — goodwill impairment (note 7) mean?
Represents a non-cash charge recognized when the carrying value of goodwill within the respiratory health segment exceeds its implied fair value. This indicates a decline in the expected future economic benefits of the acquired business, often due to market shifts or underperformance. Investors monitor this to assess the accuracy of past acquisition valuations and the current health of the segment's market position.